• QuantHealth

  Participated · Series B · Aug 2026

  QuantHealth offers an AI-driven clinical trial simulation platform that enables life sciences companies to evaluate, optimize, and de-risk clinical and commercial decisions before enrolling patients or committing capital. The company serves pharmaceutical and biotechnology organizations and is led by CEO Orr Inbar. QuantHealth is based in Tel Aviv, Israel. Following its Series B, the company plans to scale enterprise-wide impact, accelerate adoption of simulation-first clinical development, advance R&D capabilities, grow its workforce, and expand its product portfolio. The article does not disclose revenues, user counts, or prior funding rounds.

• Materialspace

  Participated · Seed · Jan 2026

  Materialspace builds a single, AI-driven software platform designed to replace the fragmented, spreadsheet-heavy workflows that dominate interior construction planning and procurement. The system ingests blueprints, product catalogs, and pricing data, then structures and optimizes that information so teams can move seamlessly from cost estimation through design and ordering. By unifying these steps, the company targets delays and inefficiencies that are exacerbated by skilled-labor shortages and increasing project complexity. Since launching its product less than a year ago, Materialspace reports rapid adoption and expansion, fueled mainly by distributors and manufacturers eager to scale without adding headcount or sacrificing margins. Co-founders and twin brothers Yoash and Nadav Palmor bring experience from manufacturing consulting and AI startups, respectively, to drive product development and market penetration. The firm positions its technology as a catalyst for fundamentally changing customer economics once critical workflows become continuous and intelligent. To support this vision, Materialspace has secured $7 million in Seed financing, its first publicly disclosed funding round.

• Turnover Labs

  Led · Seed · Oct 2024

  Turnover Labs develops electrolyzer technology that converts waste carbon dioxide from petrochemical plants into carbon monoxide for use in chemical processes. Its core innovation improves catalyst adhesion to electrodes and combines specialized chemistry and software to let electrolyzers tolerate contaminant gases present in industrial CO2 streams. This allows the company to avoid costly gas purification by operating on impure waste streams and producing a feedstock chemical used in petrochemical reactions. The approach targets on-site CO2 reuse as an alternative to capture, transport and underground sequestration. The company grew out of founder and CEO Marissa Beatty’s doctoral research into electrolyzer durability and from a fellowship with Activate. Turnover Labs recently raised a $1.4 million pre-seed round to hire engineers and simulate real-world gas streams as it iterates toward a robust industrial product.

• Nutrition Technologies

  Led · Equity · Sep 2022

  Nutrition Technologies creates a commercial replica of the natural decomposition process, using proprietary growth inoculants and black soldier flies (Hermetia illucens) to upcycle low-grade crop and food waste. The company operates a two-hectare production facility in Johor, Malaysia that bioconverts several hundreds of tonnes of organic waste every week. Its facility produces functional proteins and oils containing bioactive compounds that improve animal growth performance and health outcomes. Nutrition Technologies has conducted multiple trials of its products on fish, shrimp, poultry, piglets and pets with significant results. Its novel biofertiliser products are designed to improve soil health and increase plant resistance to disease, reducing the need for chemical pesticides. The company is led by Nick Piggott and Tom Berry and plans to use new funding to expand into new markets, launch new products, accelerate R&D and create strategic partnerships. Nutrition Technologies produces insect-based protein for fish and animal feed using black soldier fly (BSF) larvae, turning food waste into high-value feed ingredients and organic fertilisers. CEO and founder Nick Piggott says the company aims to reduce pressure on wild fisheries and the environmental impact of industrial fleets. The company secured an $8.5 million Series A led by OpenSpace Ventures and SEEDS Capital (the investment arm of Enterprise Singapore) to scale commercial production. Proceeds will fund a high-tech commercial-scale insect protein facility in Southeast Asia targeting production of over 18,000 tonnes of insect-based feed ingredients and organic fertilisers per year. Nutrition Technologies plans to move into industrial-scale production in early 2020 and says it already has demand from large feed manufacturers in Malaysia and repeat orders from South Korea and Japan. The Singapore Food Agency has approved use of black soldier fly larvae as fish food, supporting the company’s regulatory pathway for animal feed applications. The company is prioritizing animal feed markets (aquaculture, swine and poultry) and views human consumption as a limited near-term opportunity.

• Econic Technologies

  Participated · Series D · Aug 2022

  Econic Technologies develops renewable-carbon technology that allows manufacturers to produce polymers based on CO2 rather than petrochemicals. The company licenses its technology to polyols and surfactant manufacturers that supply some of the world’s most iconic consumer brands. It intends to use newly raised funds to accelerate delivery for its customers in the polyols market and to support commercialisation of its new CO2 surfactant technology. The financing round was an equity raise with the amount undisclosed. The company was founded in 2011 by Dr. Charlotte Williams and is led by CEO Keith Wiggins from Alderley Park, UK. Econic Technologies has developed catalyst technology that efficiently converts captured CO2 into a usable raw material for manufacturing polymers, initially targeting the polyurethane industry for foams, coatings, sealants, and adhesives. The company’s core product enables customers to monetise CO2 while lowering their carbon footprint and meeting demand for more sustainable products. Econic operates globally from Alderley Park near Manchester and maintains a customer demonstration facility in Runcorn. Founded in 2011 by Prof. Charlotte Williams and led by CEO Keith Wiggins, the business is focused on commercialising its catalyst and process technology. The company recently progressed its Series D with a second close intended to support commercialisation efforts. The fundraising update indicates active investor support as Econic scales toward broader market deployment. Econic Technologies develops catalyst technologies that enable manufacturers to recycle captured CO2 directly into existing processes to displace oil‑based chemicals. The technology is energy efficient, reduces cost, and lowers future emissions by decreasing use of fossil‑derived chemicals. Over the past two years the platform has progressed from laboratory to industrial pilot scale with extensive process and product validation. The company is moving toward commercial‑scale deployment first in polyols for polyurethane in collaboration with material producers and downstream users, and it sees additional opportunities in surfactants. To support commercialisation, Econic raised funding via a convertible loan that includes UK government backing. The company was spun out from Imperial College London in 2011 and operates from facilities at Alderley Park with a customer demonstration site at The Heath in Runcorn. Econic Technologies is developing and commercialising novel catalyst technologies that incorporate captured CO2 into polycarbonates via reaction with epoxides. The company plans to use the funding to support development of future catalyst generations and to expand its facilities. The round is intended to accelerate commercialisation of Econic's catalyst technology and build on traction with large global partners. Econic is a portfolio company of Imperial Innovations Group plc. Imperial Innovations committed £2.5m to the round and reported a net carrying value in Econic of £6.1m as of 31 January 2016. The fundraise is complemented by a Horizon 2020 SME award that will provide a further £2m over the next two years. Econic Technologies develops catalytic processes that use waste CO2 as a feedstock to manufacture polymers. Its catalysts enable production of polycarbonates and polyurethane polyols and long-chain polymers, with potential applications in foams, plastics and polyesters. Replacing conventional petrochemical feedstocks with CO2 can significantly reduce costs for certain polymer manufacturers. The company was founded in 2011 to commercialize research from Professor Charlotte Williams’ group at Imperial College London and is based in London, UK. Econic plans to use recent funding to further test and scale up its catalyst technology toward commercialization. The company is led by Executive Chairman David Morgan.

No current team members are available.